List of Tables
Table 1. Radiopharmaceutical CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Radiopharmaceutical Market Trends
Table 3. Radiopharmaceutical Market Drivers
Table 4. Radiopharmaceutical Market Challenges
Table 5. Radiopharmaceutical Market Restraints
Table 6. Global Radiopharmaceutical Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Radiopharmaceutical Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Radiopharmaceutical Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Radiopharmaceutical Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Radiopharmaceutical, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Radiopharmaceutical Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Radiopharmaceutical Revenue Share by Manufacturer, 2018-2023
Table 13. Global Radiopharmaceutical Sales by Manufacturer, (M Doses), 2018-2023
Table 14. Global Radiopharmaceutical Sales Share by Manufacturer, 2018-2023
Table 15. Global Radiopharmaceutical Price by Manufacturer (2018-2023) & (USD/Dose)
Table 16. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2022)
Table 18. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Radiopharmaceutical, Product Offered and Application
Table 20. Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Radiopharmaceutical in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Radiopharmaceutical Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Radiopharmaceutical Revenue Share by Players, (2018-2023)
Table 25. India Radiopharmaceutical Sales by Players, (M Doses), (2018-2023)
Table 26. India Radiopharmaceutical Sales Share by Players, (2018-2023)
Table 27. Global Radiopharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Radiopharmaceutical Sales in Volume by Region (2018-2023) & (M Doses)
Table 29. Global Radiopharmaceutical Sales in Volume Forecast by Region (2024-2029) & (M Doses)
Table 30. Global Radiopharmaceutical Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Radiopharmaceutical Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Radiopharmaceutical Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Radiopharmaceutical Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Radiopharmaceutical Sales in Volume by Country (2018-2023) & (M Doses)
Table 36. Americas Radiopharmaceutical Sales in Volume by Country (2024-2029) & (M Doses)
Table 37. EMEA Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Radiopharmaceutical Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Radiopharmaceutical Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Radiopharmaceutical Sales in Volume by Country (2018-2023) & (M Doses)
Table 41. EMEA Radiopharmaceutical Sales in Volume by Country (2024-2029) & (M Doses)
Table 42. APAC Radiopharmaceutical Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Radiopharmaceutical Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Radiopharmaceutical Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Radiopharmaceutical Sales in Volume by Country (2018-2023) & (M Doses)
Table 46. APAC Radiopharmaceutical Sales in Volume by Country (2024-2029) & (M Doses)
Table 47. Bracco Imaging Company Information
Table 48. Bracco Imaging Description and Business Overview
Table 49. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 50. Bracco Imaging Radiopharmaceutical Product
Table 51. Bracco Imaging Recent Development
Table 52. Bayer Company Information
Table 53. Bayer Description and Business Overview
Table 54. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 55. Bayer Radiopharmaceutical Product
Table 56. Bayer Recent Development
Table 57. Mallinckrodt Company Information
Table 58. Mallinckrodt Description and Business Overview
Table 59. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 60. Mallinckrodt Radiopharmaceutical Product
Table 61. Mallinckrodt Recent Development
Table 62. Nordion Company Information
Table 63. Nordion Description and Business Overview
Table 64. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 65. Nordion Radiopharmaceutical Product
Table 66. Nordion Recent Development
Table 67. Triad Isotopes Company Information
Table 68. Triad Isotopes Description and Business Overview
Table 69. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 70. Triad Isotopes Radiopharmaceutical Product
Table 71. Triad Isotopes Recent Development
Table 72. Lantheus Company Information
Table 73. Lantheus Description and Business Overview
Table 74. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 75. Lantheus Radiopharmaceutical Product
Table 76. Lantheus Recent Development
Table 77. IBA Group Company Information
Table 78. IBA Group Description and Business Overview
Table 79. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 80. IBA Group Radiopharmaceutical Product
Table 81. IBA Group Recent Development
Table 82. GE Healthcare Company Information
Table 83. GE Healthcare Description and Business Overview
Table 84. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 85. GE Healthcare Radiopharmaceutical Product
Table 86. GE Healthcare Recent Development
Table 87. China Isotope & Radiation Company Information
Table 88. China Isotope & Radiation Description and Business Overview
Table 89. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 90. China Isotope & Radiation Radiopharmaceutical Product
Table 91. China Isotope & Radiation Recent Development
Table 92. Jubilant Pharma Company Information
Table 93. Jubilant Pharma Description and Business Overview
Table 94. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 95. Jubilant Pharma Radiopharmaceutical Product
Table 96. Jubilant Pharma Recent Development
Table 97. Eli Lilly Company Information
Table 98. Eli Lilly Description and Business Overview
Table 99. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 100. Eli Lilly Radiopharmaceutical Product
Table 101. Eli Lilly Recent Development
Table 102. Advanced Accelerator Applications Company Information
Table 103. Advanced Accelerator Applications Description and Business Overview
Table 104. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 105. Advanced Accelerator Applications Radiopharmaceutical Product
Table 106. Advanced Accelerator Applications Recent Development
Table 107. SIEMENS Company Information
Table 108. SIEMENS Description and Business Overview
Table 109. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 110. SIEMENS Radiopharmaceutical Product
Table 111. SIEMENS Recent Development
Table 112. Dongcheng Company Information
Table 113. Dongcheng Description and Business Overview
Table 114. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 115. Dongcheng Radiopharmaceutical Product
Table 116. Dongcheng Recent Development
Table 117. Navidea Company Information
Table 118. Navidea Description and Business Overview
Table 119. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 120. Navidea Radiopharmaceutical Product
Table 121. Navidea Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Radiopharmaceutical Customers List
Table 125. Radiopharmaceutical Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Radiopharmaceutical Market Size 2018-2029 (US$ Million)
Figure 4. Global Radiopharmaceutical Sales 2018-2029 (M Doses)
Figure 5. India Radiopharmaceutical Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Radiopharmaceutical Market Size 2018-2029 (US$ Million)
Figure 7. India Radiopharmaceutical Sales 2018-2029 (M Doses)
Figure 8. India Radiopharmaceutical Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Radiopharmaceutical Market Share in Global, in Volume (M Doses) 2018-2029
Figure 10. Radiopharmaceutical Report Years Considered
Figure 11. Product Picture of Actinium-225
Figure 12. Product Picture of Lutetium-177
Figure 13. Product Picture of Radium-223
Figure 14. Product Picture of Holmium-166
Figure 15. Product Picture of Other
Figure 16. Global Radiopharmaceutical Market Share by Type in 2022 & 2029
Figure 17. Global Radiopharmaceutical Sales in Value by Type (2018-2029) & (US$ Million)
Figure 18. Global Radiopharmaceutical Sales Market Share in Value by Type (2018-2029)
Figure 19. Global Radiopharmaceutical Sales by Type (2018-2029) & (M Doses)
Figure 20. Global Radiopharmaceutical Sales Market Share in Volume by Type (2018-2029)
Figure 21. Global Radiopharmaceutical Price by Type (2018-2029) & (USD/Dose)
Figure 22. India Radiopharmaceutical Market Share by Type in 2022 & 2029
Figure 23. India Radiopharmaceutical Sales in Value by Type (2018-2029) & (US$ Million)
Figure 24. India Radiopharmaceutical Sales Market Share in Value by Type (2018-2029)
Figure 25. India Radiopharmaceutical Sales by Type (2018-2029) & (M Doses)
Figure 26. India Radiopharmaceutical Sales Market Share in Volume by Type (2018-2029)
Figure 27. India Radiopharmaceutical Price by Type (2018-2029) & (USD/Dose)
Figure 28. Product Picture of Oncology
Figure 29. Product Picture of Cardiology
Figure 30. Product Picture of Other
Figure 31. Global Radiopharmaceutical Market Share by Application in 2022 & 2029
Figure 32. Global Radiopharmaceutical Sales in Value by Application (2018-2029) & (US$ Million)
Figure 33. Global Radiopharmaceutical Sales Market Share in Value by Application (2018-2029)
Figure 34. Global Radiopharmaceutical Sales by Application (2018-2029) & (M Doses)
Figure 35. Global Radiopharmaceutical Sales Market Share in Volume by Application (2018-2029)
Figure 36. Global Radiopharmaceutical Price by Application (2018-2029) & (USD/Dose)
Figure 37. India Radiopharmaceutical Market Share by Application in 2022 & 2029
Figure 38. India Radiopharmaceutical Sales in Value by Application (2018-2029) & (US$ Million)
Figure 39. India Radiopharmaceutical Sales Market Share in Value by Application (2018-2029)
Figure 40. India Radiopharmaceutical Sales by Application (2018-2029) & (M Doses)
Figure 41. India Radiopharmaceutical Sales Market Share in Volume by Application (2018-2029)
Figure 42. India Radiopharmaceutical Price by Application (2018-2029) & (USD/Dose)
Figure 43. Americas Radiopharmaceutical Sales in Volume Growth Rate 2018-2029 (M Doses)
Figure 44. Americas Radiopharmaceutical Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 45. Americas Radiopharmaceutical Sales by Type (2018-2029) & (M Doses)
Figure 46. Americas Radiopharmaceutical Sales Market Share in Volume by Type (2018-2029)
Figure 47. Americas Radiopharmaceutical Sales by Application (2018-2029) & (M Doses)
Figure 48. Americas Radiopharmaceutical Sales Market Share in Volume by Application (2018-2029)
Figure 49. United States Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Canada Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. Mexico Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 53. EMEA Radiopharmaceutical Sales in Volume Growth Rate 2018-2029 (M Doses)
Figure 54. EMEA Radiopharmaceutical Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 55. EMEA Radiopharmaceutical Sales by Type (2018-2029) & (M Doses)
Figure 56. EMEA Radiopharmaceutical Sales Market Share in Volume by Type (2018-2029)
Figure 57. EMEA Radiopharmaceutical Sales by Application (2018-2029) & (M Doses)
Figure 58. EMEA Radiopharmaceutical Sales Market Share in Volume by Application (2018-2029)
Figure 59. Europe Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. Middle East Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 61. Africa Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 62. China Radiopharmaceutical Sales in Volume Growth Rate 2018-2029 (M Doses)
Figure 63. China Radiopharmaceutical Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 64. China Radiopharmaceutical Sales by Type (2018-2029) & (M Doses)
Figure 65. China Radiopharmaceutical Sales Market Share in Volume by Type (2018-2029)
Figure 66. China Radiopharmaceutical Sales by Application (2018-2029) & (M Doses)
Figure 67. China Radiopharmaceutical Sales Market Share in Volume by Application (2018-2029)
Figure 68. APAC Radiopharmaceutical Sales in Volume Growth Rate 2018-2029 (M Doses)
Figure 69. APAC Radiopharmaceutical Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 70. APAC Radiopharmaceutical Sales by Type (2018-2029) & (M Doses)
Figure 71. APAC Radiopharmaceutical Sales Market Share in Volume by Type (2018-2029)
Figure 72. APAC Radiopharmaceutical Sales by Application (2018-2029) & (M Doses)
Figure 73. APAC Radiopharmaceutical Sales Market Share in Volume by Application (2018-2029)
Figure 74. Japan Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. South Korea Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. China Taiwan Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. Southeast Asia Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 78. India Radiopharmaceutical Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 79. Radiopharmaceutical Value Chain
Figure 80. Radiopharmaceutical Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
